8101 - 8150 of 8399 Results
Title
Year
-
RESTRICTEDTitle: Chaperone-mediated autophagy: machinery, regulation and biological consequencesJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 68Issue #: 5Start Page: 749End Page: 763Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-010-0565-6Citation Count: 111
-
OPENTitle: Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 686End Page: 687Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.09.007Best OA location URL: https://europepmc.org/articles/pmc4381965?pdf=renderCitation Count: 40
-
OPENTitle: CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 1Start Page: 23End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-010-0485-5Best OA location URL: https://europepmc.org/articles/pmc3090073?pdf=renderCitation Count: 13
-
OPENTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://www.rmmj.org.il/userimages/13/0/PublishFiles/13Article.pdfCitation Count: 8
-
RESTRICTEDTitle: PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 2Issue #: 52Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3001059Best OA location URL: https://europepmc.org/articles/pmc3129986?pdf=renderCitation Count: 709
-
OPENTitle: A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms1085Best OA location URL: https://www.nature.com/articles/ncomms1085.pdfCitation Count: 151
-
RESTRICTEDTitle: Biomarkers in Parkinson’s disease: a funder’s perspectiveJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 723End Page: 729Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.89Citation Count: 17
-
RESTRICTEDTitle: Toxicological and pathophysiological roles of reactive oxygen and nitrogen speciesJournal Name: ToxicologyPublisher: Elsevier BVVol: 276Issue #: 2Start Page: 85End Page: 94Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tox.2010.07.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237863Citation Count: 181
-
RESTRICTEDTitle: Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosisJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 701End Page: 712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.94Best OA location URL: https://europepmc.org/articles/pmc3049925?pdf=renderCitation Count: 119
-
OPENTitle: Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysisJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 82Issue #: 5Start Page: 564End Page: 568Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp.2010.222042Best OA location URL: https://europepmc.org/articles/pmc4646086?pdf=renderCitation Count: 100
-
RESTRICTEDTitle: Estimation of Particulate Mass and Manganese Exposure Levels among WeldersJournal Name: The Annals of Occupational HygienePublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/annhyg/meq069Best OA location URL: https://academic.oup.com/annweh/article-pdf/55/1/113/11209915/meq069.pdfCitation Count: 44
-
RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 67
-
OPENTitle: A comparative study of Lrrk2 function in primary neuronal culturesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 650End Page: 655Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018Best OA location URL: https://europepmc.org/articles/pmc3159957?pdf=renderCitation Count: 81
-
OPENTitle: Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 2-3Start Page: 284End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.09.011Best OA location URL: https://europepmc.org/articles/pmc3820002?pdf=renderCitation Count: 20
- Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease2010OPENTitle: Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 226Issue #: 1Start Page: 207End Page: 217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.09.001Best OA location URL: https://europepmc.org/articles/pmc3108022?pdf=renderCitation Count: 55
-
OPENTitle: Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairmentJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 120Issue #: 6Start Page: 827End Page: 828Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-010-0744-4Best OA location URL: https://europepmc.org/articles/pmc3100801?pdf=renderCitation Count: 83
-
OPENTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Best OA location URL: https://europepmc.org/articles/pmc3005012?pdf=renderCitation Count: 48
-
OPENTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://europepmc.org/articles/pmc2978754?pdf=renderCitation Count: 173
-
OPENTitle: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2536End Page: 2541Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23314Best OA location URL: https://europepmc.org/articles/pmc2978749?pdf=renderCitation Count: 64
-
RESTRICTEDTitle: Systemic Weakness After Therapeutic Injections of Botulinum Toxin AJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 33Issue #: 5Start Page: 243End Page: 247Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0b013e3181f5329eBest OA location URL: https://europepmc.org/articles/pmc3563356?pdf=renderCitation Count: 79
-
OPENTitle: Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 16Issue #: 9Start Page: 998End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nm.2199Best OA location URL: https://europepmc.org/articles/pmc2935926?pdf=renderCitation Count: 368
-
OPENTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://europepmc.org/articles/pmc2978804?pdf=renderCitation Count: 23
-
OPENTitle: Heart rate changes during freezing of gait in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 14Start Page: 2346End Page: 2354Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23280Best OA location URL: https://europepmc.org/articles/pmc2964413?pdf=renderCitation Count: 58
-
RESTRICTEDTitle: Glutamate Receptor Ion Channels: Structure, Regulation, and FunctionJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 62Issue #: 3Start Page: 405End Page: 496Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.109.002451Best OA location URL: https://europepmc.org/articles/pmc2964903?pdf=renderCitation Count: 2923
-
OPENTitle: Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 42Issue #: 9Start Page: 781End Page: 785Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ng.642Best OA location URL: https://europepmc.org/articles/pmc2930111?pdf=renderCitation Count: 754
-
RESTRICTEDTitle: Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson DiseaseJournal Name: ChestPublisher: Elsevier BVVol: 138Issue #: 6Start Page: 1426End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1378/chest.10-0342Citation Count: 87
-
OPENTitle: Postmortem interval effect on RNA and gene expression in human brain tissueJournal Name: Cell and Tissue BankingPublisher: Springer Science and Business Media LLCVol: 12Issue #: 4Start Page: 311End Page: 318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10561-010-9210-8Best OA location URL: https://europepmc.org/articles/pmc3343031?pdf=renderCitation Count: 140
-
OPENTitle: Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neuronsJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 282End Page: 292Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/cdd.2010.92Best OA location URL: https://www.nature.com/articles/cdd201092.pdfCitation Count: 179
-
OPENTitle: Genetic variability at the PARK16 locusJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 12Start Page: 1356End Page: 1359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ejhg.2010.125Best OA location URL: https://www.nature.com/articles/ejhg2010125.pdfCitation Count: 91
-
RESTRICTEDTitle: Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesJournal Name: Journal of NeurochemistryPublisher: WileyVol: 114Issue #: 5Start Page: 1261End Page: 1276Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2010.06834.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2010.06834.xCitation Count: 30
-
OPENTitle: Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutationsJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1791End Page: 1800Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23221Best OA location URL: https://europepmc.org/articles/pmc6005705?pdf=renderCitation Count: 239
-
OPENTitle: LRRK2 variation and Parkinson's disease in African AmericansJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1973End Page: 1976Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23163Best OA location URL: https://europepmc.org/articles/pmc2939165?pdf=renderCitation Count: 13
-
OPENTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Best OA location URL: https://europepmc.org/articles/pmc2939261?pdf=renderCitation Count: 42
-
OPENTitle: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 40Issue #: 3Start Page: 503End Page: 517Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.07.010Best OA location URL: https://europepmc.org/articles/pmc2955774?pdf=renderCitation Count: 266
-
OPENTitle: Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localizationJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 430Issue #: 3Start Page: 405End Page: 413Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20100784Best OA location URL: https://portlandpress.com/biochemj/article-pdf/430/3/405/664434/bj4300405.pdfCitation Count: 373
-
OPENTitle: 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localizationJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 430Issue #: 3Start Page: 393End Page: 404Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1042/bj20100483Best OA location URL: https://portlandpress.com/biochemj/article-pdf/430/3/393/878058/bj4300393.pdfCitation Count: 384
-
RESTRICTEDTitle: Characterization of axon guidance cue sensitivity of human embryonic stem cell-derived dopaminergic neuronsJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 45Issue #: 4Start Page: 324End Page: 334Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2010.07.004Citation Count: 22
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease2010OPENTitle: Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 120Issue #: 8Start Page: 2745End Page: 2754Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci42642Best OA location URL: http://www.jci.org/articles/view/42642/files/pdfCitation Count: 397
-
OPENTitle: Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-Selective N-Methyl-d-aspartate Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 53Issue #: 15Start Page: 5476End Page: 5490Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm100027pBest OA location URL: https://europepmc.org/articles/pmc2920070?pdf=renderCitation Count: 84
-
OPENTitle: Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutationsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 33Issue #: 4Start Page: 814End Page: 823Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2010.05.009Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2010.05.009Citation Count: 213
-
OPENTitle: Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 20Issue #: 17Start Page: 5175End Page: 5178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2010.07.007Best OA location URL: https://europepmc.org/articles/pmc2922490?pdf=renderCitation Count: 29
-
OPENTitle: Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementiaJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 225Issue #: 1Start Page: 210End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.06.017Best OA location URL: https://europepmc.org/articles/pmc2922478?pdf=renderCitation Count: 191
-
OPENTitle: Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 VectorsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 1490End Page: 1495Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2010.114Best OA location URL: http://www.cell.com/article/S1525001616310991/pdfCitation Count: 80
-
OPENTitle: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 480Issue #: 1Start Page: 78End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009Best OA location URL: https://europepmc.org/articles/pmc2943649?pdf=renderCitation Count: 198
-
OPENTitle: Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD)Journal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 11Start Page: 1530End Page: 1537Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23151Best OA location URL: https://europepmc.org/articles/pmc4775095?pdf=renderCitation Count: 25
-
OPENTitle: Low‐dose bafilomycin attenuates neuronal cell death associated with autophagy‐lysosome pathway dysfunctionJournal Name: Journal of NeurochemistryPublisher: WileyVol: 114Issue #: 4Start Page: 1193End Page: 1204Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2010.06838.xBest OA location URL: https://europepmc.org/articles/pmc2910188?pdf=renderCitation Count: 74
-
OPENTitle: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevinJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 10Start Page: 695End Page: 699Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3bBest OA location URL: https://europepmc.org/articles/pmc2889226?pdf=renderCitation Count: 14
-
OPENTitle: Risk of sleep-disordered breathing in Parkinson's diseaseJournal Name: Sleep and BreathingPublisher: Springer Science and Business Media LLCVol: 15Issue #: 3Start Page: 471End Page: 478Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11325-010-0362-3Best OA location URL: https://europepmc.org/articles/pmc2978748?pdf=renderCitation Count: 43
-
OPENTitle: Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged miceJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 107Issue #: 21Start Page: 9879End Page: 9884Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1004676107Best OA location URL: https://europepmc.org/articles/pmc2906862?pdf=renderCitation Count: 488
-
RESTRICTEDTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Citation Count: 150